Skip to Main Content

Author Details

Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
1959
513
91
PMIDPaper TitleJournal TitlePublished Year
36929942Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions.J Natl Cancer Inst2023
36707629FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.Eur J Hum Genet2023
36929942Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions.J Natl Cancer Inst2023
37168552Multi-trait genome-wide association study identifies a novel endometrial cancer risk locus that associates with testosterone levels.iScience2023
36991492CRISPR screens identify gene targets at breast cancer risk loci.Genome Biol2023
37503126Understanding the genetic complexity of puberty timing across the allele frequency spectrum.medRxiv2023
37503126Understanding the genetic complexity of puberty timing across the allele frequency spectrum.medRxiv2023
36991492CRISPR screens identify gene targets at breast cancer risk loci.Genome Biol2023
37168552Multi-trait genome-wide association study identifies a novel endometrial cancer risk locus that associates with testosterone levels.iScience2023
36707629FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.Eur J Hum Genet2023
34320204Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.J Natl Cancer Inst2022
36041172Coffee consumption and risk of endometrial cancer: a pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium (E2C2).Am J Clin Nutr2022
35585550Breast cancer risks associated with missense variants in breast cancer susceptibility genes.Genome Med2022
35585550Breast cancer risks associated with missense variants in breast cancer susceptibility genes.Genome Med2022
35501337Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.NPJ Breast Cancer2022
36210504Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.J Natl Cancer Inst2022
36205748Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.Genet Med2022
36205748Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.Genet Med2022
33567813Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia.Haematologica2022
34320204Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.J Natl Cancer Inst2022
35042965Rare germline copy number variants (CNVs) and breast cancer risk.Commun Biol2022
34906479Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.Genet Med2022
35077220Cancer Risks Associated With <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variants.J Clin Oncol2022
35263119TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.J Clin Oncol2022
35084436Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.JAMA Oncol2022
35585550Breast cancer risks associated with missense variants in breast cancer susceptibility genes.Genome Med2022
35585550Breast cancer risks associated with missense variants in breast cancer susceptibility genes.Genome Med2022
35501337Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.NPJ Breast Cancer2022
36210504Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.J Natl Cancer Inst2022
36041172Coffee consumption and risk of endometrial cancer: a pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium (E2C2).Am J Clin Nutr2022
36205748Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.Genet Med2022
36205748Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.Genet Med2022
33567813Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia.Haematologica2022
35042965Rare germline copy number variants (CNVs) and breast cancer risk.Commun Biol2022
34906479Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.Genet Med2022
35084436Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.JAMA Oncol2022
35263119TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.J Clin Oncol2022
35077220Cancer Risks Associated With <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variants.J Clin Oncol2022
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
32359158Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.J Natl Cancer Inst2021
33471991Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.N Engl J Med2021
33471991Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.N Engl J Med2021
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
33529165RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors.J Clin Invest2021
33990587Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.Nat Commun2021
34146516Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.Am J Hum Genet2021
34341517Mendelian randomisation study of smoking exposure in relation to breast cancer risk.Br J Cancer2021
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
32976626Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analyses.Int J Cancer2021
32851660Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer.Int J Cancer2021
  • 1 - 50 of 1,026

Recommended Authors

Frederick National Laboratory for Cancer Research (FNLCR), Inc.
Career Start Year 2012
Number of shared co-authors 31
The Broad Institute of Harvard and MIT
Career Start Year 2005
Number of shared co-authors 49
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 53
Guardant Health Inc.
Career Start Year 2004
Number of shared co-authors 22
The Ohio State University Comprehensive Cancer Center, Comprehensive Cancer Center
Career Start Year 2002
Number of shared co-authors 20
Memorial University
Career Start Year 1999
Number of shared co-authors 10
Uppsala University
Career Start Year 1999
Number of shared co-authors 3
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 30
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 12
Novartis Pharmaceuticals
Career Start Year 1995
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 13
The University of MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 18
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 51
Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 116
University of British Columbia
Career Start Year 1993
Number of shared co-authors 59
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 14
University of South Carolina
Career Start Year 1993
Number of shared co-authors 4
National Center for Advancing Translational Sciences
Career Start Year 1993
Number of shared co-authors 14
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 15
Stanford University
Career Start Year 1989
Number of shared co-authors 28
University of Sydney
Career Start Year 1989
Number of shared co-authors 70
Mt Sinai Hospital
Career Start Year 1988
Number of shared co-authors 30
deCODE genetics/Amgen Inc.
Career Start Year 1988
Number of shared co-authors 80
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 27
National Cancer Institute, National Institutes of Health
Career Start Year 1986
Number of shared co-authors 39
University of Texas Health San Antonio
Career Start Year 1984
Number of shared co-authors 38
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 26
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 46
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 7
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 54

Collaborators

University of Cambridge
Co-authored papers 208
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 196
Mayo Clinic
Co-authored papers 171
German Cancer Research Center (DKFZ)
Co-authored papers 161
University of Toronto
Co-authored papers 151
Co-authored papers 148
Instituto de Salud Carlos III
Co-authored papers 145
QIMR Berghofer Medical Research Institute
Co-authored papers 143
Otto-Friedrich-University Bamberg
Co-authored papers 143
Pomeranian Medical University
Co-authored papers 131
QIMR Berghofer Medical Research Institute
Co-authored papers 129
Co-authored papers 122
National Cancer Institute
Co-authored papers 122
University of California irvine
Co-authored papers 121
Co-authored papers 114
Co-authored papers 113
Ospedale Circolo e Fondazione Macchi
Co-authored papers 112
Co-authored papers 108
QIMR Berghofer Medical Research Institute
Co-authored papers 105
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 98
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 95
University of Southern California
Co-authored papers 93
Mayo Clinic College of Medicine
Co-authored papers 91
Cedars-Sinai Medical Center
Co-authored papers 91
National Cancer Institute, National Institutes of Health
Co-authored papers 84
Duke School of Medicine
Co-authored papers 83
David Geffen School of Medicine, University of California los angeles
Co-authored papers 79
Co-authored papers 78
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 78
University of Southern California
Co-authored papers 77